• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: DEPUY INTERNATIONAL LTD - 8010379 DEPUY ASR XL FEM IMP SIZE 45; HIP FEMORAL HEAD

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

DEPUY INTERNATIONAL LTD - 8010379 DEPUY ASR XL FEM IMP SIZE 45; HIP FEMORAL HEAD Back to Search Results
Catalog Number 999890145
Device Problem Insufficient Information (3190)
Patient Problems Pain (1994); Ambulation Difficulties (2544); No Code Available (3191)
Event Date 03/12/2014
Event Type  Injury  
Event Description
Asr revision; asr xl - right; reason(s) for revision: pain.Update received: (b)(4) 2014 - added surgeon: dr (b)(6), added hospital: (b)(6).Added further reason for revision: difficulty walking.
 
Event Description
Asr revision, asr xl - right, reason(s) for revision: pain.
 
Manufacturer Narrative
If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.No 510(k) number provided because this implant is sold internationally with different indications for use; it is currently sold in the us under a different part number.The correction/removal reporting number listed applies to the corresponding product code sold domestically.The asr platform was voluntarily recalled from the market in august 2010, and the asr product codes are now considered inactive.Further investigation of this individual incident will not be undertaken, as there is an ongoing investigation regarding the root cause(s) and/or corrective actions.Ref.(b)(4).Depuy considers the investigation closed at this time.Should the product and/or additional information be received, the investigation will be re-opened.
 
Manufacturer Narrative
Depuy still considers the investigation closed.Additional narrative: if information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
 
Manufacturer Narrative
Product complaint # (b)(4).Depuy synthes is submitting this report pursuant to the provisions of 21 cfr, part 803.This report may be based on information which depuy synthes has not been able to investigate or verify prior to the required reporting date.This report does not reflect a conclusion by fda, depuy synthes or its employees that the report constitutes an admission that the device, depuy synthes, or its employees caused or contributed to the potential event described in this report.No code available (3191) used to capture device revision or replacement.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
DEPUY ASR XL FEM IMP SIZE 45
Type of Device
HIP FEMORAL HEAD
Manufacturer (Section D)
DEPUY INTERNATIONAL LTD - 8010379
st. anthony's road
leeds LS11 8 DT
UK  LS11 8 DT
MDR Report Key3703723
MDR Text Key4306840
Report Number1818910-2014-15293
Device Sequence Number1
Product Code KXA
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,foreign,other
Remedial Action Recall
Type of Report Initial,Followup,Followup
Report Date 03/20/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Physician
Device Catalogue Number999890145
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 03/20/2014
Initial Date FDA Received03/27/2014
Supplement Dates Manufacturer ReceivedNot provided
04/25/2020
Supplement Dates FDA Received04/07/2014
05/15/2020
Is This a Reprocessed and Reused Single-Use Device? No
Removal/Correction NumberZ-1749/1816-2011
Patient Sequence Number1
Treatment
ASR ACETABULAR IMPLANT 50; TAPER SLEEVE ADAPTER 12/14 +2; UNKNOWN HIP FEMORAL STEM
Patient Outcome(s) Required Intervention;
Patient Age55 YR
-
-